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The present investigation has been undertaken to study the antioxidant, antitumor, and
wound healing properties of Rubus ellipticus. The R. ellipticus leaves were extracted us-
ing organic solvents in Soxhlet and were subjected to in vitro antioxidant assays. R. ellip-
ticus leaf methanol (RELM) extract, which showed higher in vitro antioxidant activity,
was taken for the evaluation of in vivo antioxidant, antitumor, and wound healing prop-
erties. Acute oral and dermal toxicity studies showed the safety of RELM up to a dose of
2 g/kg. A significant wound healing property was observed in incision, excision, and
Staphylococcus aureus-induced infected wound models in the treatment groups
compared to the control group. A complete epithelialization period was noticed during
the 13th day and the 19th day. A 250-mg/kg treatment was found to prolong the life span
of mice with Ehrlich ascite carcinoma (EAC; 46.76%) and to reduce the volume of Dalton’s
lymphoma ascite (DLA) solid tumors (2.56 cm3). The present study suggests that R. ellip-
ticus is a valuable natural antioxidant and that it is immensely effective for treating skin
diseases, wounds, and tumors.1. Introduction
Wound healing is the body’s natural process of regenerating
in a wounded area. When an individual is wounded, a set
of biochemical events take place, i.e., inflammatory,of Botany, Bharathiar University,
arimelazhagan).
3.10.002
acopuncture Institute.proliferative, and remodeling phases [1]. The bioactive
compound that promotes these events can be therapeuti-
cally used to improve the wound healing process. Reactive
oxygen species (ROS) play a vital role in wound healing.
Superoxide is rapidly converted to H2O2 by superoxideMaruthamalai Main Road, Coimbatore 641 046, Tamil Nadu, India.
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of other oxidants that are more stabledthis suggests that
the wound site is rich in oxidants [2]. Antioxidants there-
fore enhance wound healing by reducing the damage
caused by radicals. Hence, plants showing antioxidant
properties could also have wound healing activity. The
target of many research studies has been the discovery of
natural and synthetic compounds that can be used in the
prevention and/or treatment of cancer. Several studies
have shown that the extracts from different medicinal
plants have great significance in reducing the risk of inci-
dence and progression of tumors.
The genus Rubus is very diverse. It includes over 750
species in 12 subgenera and is found in all continents except
Antarctica [3]. R. ellipticus is a weedy raspberry, well
established in disturbed wet forests with an elevation of
548e1700 m, and thrives in sunny open pastures as well as
deep rain forests [4]. Previously reported as an in vitro
antioxidant, its traditional uses and pharmacological prop-
erties, such as anti-inflammatory, analgesic, and antipyretic
activities [5], encouraged us to carry out this study. The
Rubus species is well known for its pharmacological proper-
ties; a survey of the literature revealed that the antioxidant,
antitumor, and wound healing potential of this plant has not
been fully evaluated. Keeping this in mind, the present
investigation was undertaken to study the antioxidant,
antitumor, and wound healing activities of R. ellipticus leaf
and to put forward a scope to develop an effective drug for
the treatment of wounds, bacterial infections, and tumors.
2. Materials and methods
2.1. Plant material and extract preparation
Fresh R. ellipticus plant was collected from Marayoor Shola
forest, Kerala, India and was identified by the Botanical
Survey of India (Tamil Nadu, India; voucher specimen No.
BSI/SRC/5/23/2010-11/Tech.1659). The powdered leaf was
extracted successively in Soxhlet (Borosil Glass Works
Limited 1101, Crescenzo, G-Block, Opp. MCA club, Bandra
Kurla Complex, Mumbai 400051, India) using organic sol-
vents. The chemicals such as DPPH, Nitric oxide, Superox-
ide, Tris HCl, SOD, Catalase, GSH and GPx were purchased
from Sigma Aldrich Chemicals (Bommansandar Jigani Link
Road Industrial Area, Bangalore 560100, Karnataka, India).
2.2. Determination of in vitro antioxidant activity
The antioxidant activities of the leaf extracts were deter-
mined in terms of hydrogen donating or radical scavenging
ability using the stable radical 2,2-diphenyl-1-picrylhy-
drazyl (DPPH), according to the method of Blois [6]. Nitric
oxide [7] and superoxide [8] radical scavenging activities of
the R. ellipticus leaf extracts were also assayed to confirm
its antioxidant potential.
2.3. Determination of in vivo antioxidant activity
All of the animal experimental protocol was subjected to
scrutiny by the institutional animal ethics committee forexperimental clearance (Kovai Medical Center Research
and Educational Trust, KMCRET/Ph.D/03/2011). The acute
toxicity studies were carried out by following Organization
for Economic Co-operation and Development (OECD)
guidelines [9]. Thirty Swiss albino male mice were divided
into five groups of six animals and treated orally with
different doses of R. ellipticus leaf methanol (RELM)
extract dissolved in 0.1% carboxy methyl cellulose (CMC) for
30 days: Group I, normal; Group II, control treated with
0.1% CMC; Group III, 50 mg/kg body weight (b. wt); Group
IV, 100 mg/kg b. wt; and Group V, 250 mg/kg b. wt.
At the end of the experiment, animals were sacrificed,
the liver was excised and washed in ice-cold trisamino-
methane hydrochloride (TriseHCl) buffer (0.1 M, pH 7.4),
and cytosolic samples of liver homogenate were prepared
by centrifugation at 9500 x g for 30 minutes at 4C.
The estimation of total protein was carried out by
Lowry’s method [10]. The following parameters were
assayed in liver to assess the oxidative stress: SOD activity
was measured by the nitro blue tetrazolium (NBT) reduc-
tion method of McCord and Fridovich [11]. Catalase (CAT)
activity was estimated by the method of Aebi [12] by
measuring the rate of decomposition of hydrogen peroxide
at 240 nm. Glutathione (GSH) activity was assayed by the
method of Moron [13]; assay of glutathione peroxidase
(GPX) was carried out by the method of Hafeman [14] based
on the degradation of H2O2 in the presence of GSH.
2.4. Wound healing activity
Wistar male rats (150e250 g) were used to assess the wound
healing property (Rats, mice: Small animals breeding sta-
tion, College of Veterinary and Animal Sciences, Mannuthy,
Trissur, India; Cell lines: Amala Cancer Research Centre,
Trissur, India). The experimental protocol was subjected to
the scrutiny of the institutional animal ethical committee
for experimental clearance. Acute dermal toxicity was
checked as per OECD guidelines 404 [15]. The most
commonly used trituration method as mentioned in British
Pharmacopeia [12] was followed for extract ointment
preparation (1% and 2%). The animals were divided into
groups (8 animals per group) as follows:
Excision model: Group I, control; Group II, control
treated with simple ointment base; Group III, Betadine 5%
(w/w); Group IV, RELM 1% (w/w); and Group V, RELM 2%
(w/w).
Infected model: Group I, control; Group II, control
treated with simple ointment base; Group III, Betadine 5%
(w/w); Group IV, RELM 1% (w/w); Group V, RELM 2% (w/w);
and Group VI, Neomycin 5% (w/w).
Incision model: Group I, control; Group III, Betadine 5%
(w/w); Group IV, RELM 1% (w/w); and Group V, RELM 2%
(w/w).
2.4.1. Excision and infected wound models
An excision wound of 1.5 cm in diameter and 0.2 cm depth
was created on the shaved dorsal side. In the infected
model, 0.1 mL of saline containing 106 colony forming units
(CFU)/mL of Staphylococcus aureus suspension was swab-
bed on the wounded area. The healing property was eval-
uated by wound contraction percentage and closure time.
Table 1 Free radical scavenging activities of RELM.
Sample DPPH radical scavenging
activity (IC50 mg/mL)
Nitric oxide radical scavenging
(%inhibition) (100 mg/mL)
Superoxide radical scavenging
(%inhibition) (100 mg/mL)
Petroleum ether 182.48  3.43c 26.54  2.74c 59.23  0.83c
Chloroform 270.27  2.44d 34.09  3.34c 45.34  1.45c
Acetone 7.05  2.02a 70.37  2.36b 65.71  2.07b
Methanol 6.96  2.32a 71.08  3.34b 66.08  2.11b
Hot water 7.39  1.23a 20.01  3.68d 63.44  0.54b
BHT 13.18  1.43b 91.02  1.77a 94.20  2.12a
BHA 4.88  1.45a d 94.70  1.78a
Rutin 5.81  2.34a 93.24  1.96a d
Quercetin 4.12  1.67a d d
Values are mean of triplicate determinations (n Z 3)  standard deviation (SD).
BHA Z butylated hydroxyanisole; BHT Z butylated hydroxytoluene; DPPH Z 2,2-diphenyl-1-picrylhydrazyl; IC50 Z an inhibitory con-
centration 50; RELM Z Rubus ellipticus leaf methanol.
Statistically significant at p < 0.001 where a > b > c > d in each assay.
136 B.P. George et al.The granuloma tissue excised from the wound site was used
for the estimation of SOD levels and histopathological
analysis [16e19].
2.4.2. Incision model
A long incision of 6 cm was made through the full thickness
of the skin. The wounds were closed with sutures 1 cm
apart using a surgical thread and a curved needle. The
drugs were topically applied once daily for 10 days. All the
sutures were removed on the 10th day and tensile strength
was measured [20]:
Tensile strengthZ
Breaking force ðNÞ
Area ðcm2Þ
where area Z thickness  width.
2.5. Effect of RELM extract on solid and ascites
tumor development
Dalton’s lymphoma ascite (DLA) cell lines (106 cells/animal)
were injected subcutaneously into the right hind limb of
Swiss albino mice for solid tumor development and divided
into five groups containing six mice in each group [21]. Group
I served as tumor control and received CMC (0.1%). Group II
was treated with cyclophosphamide (10 mg/kg b. wt).
Groups III, IV, and V were treated with RELM extract
at 50 mg/kg b. wt, 100 mg/kg b. wt, and 250 mg/kg b. wt
doses, respectively. The treatments were administered
orally after 24 hours of DLA cell inoculation and continuedTable 2 Effect of RELM on antioxidant enzymes in liver.
Group Glutathione
(nmol/mg protein)
Glutathion
(U/mg
Normal 10.76  1.08 9.73
Control (0.1% CMC) 9.33  1.22 10.28
RELM (100 mg/kg b. wt) 11.89  0.53* 12.89
RELM (250 mg/kg b. wt) 12.78  0.98y 14.09
Values are expressed as mean  standard error of the mean (SEM; n
Significantly different at *p < 0.01,
y
p < 0.001, when compared to c
RELM Z Rubus ellipticus leaf methanol.once daily for 10 days. The initial diameter of the right hind
limb was noted using vernier calipers. The tumor volume (V)
was measured every 3rd day and recorded up to 1 month:
VZ 4=3p r21  r2
where r1 and r2 are the radii of tumors in two different
planes.
Male Swiss albino mice were injected with EAC cell lines
(106) intraperitoneally for the development of ascites tumor
[22] After 24 hours of tumor inoculation, the animals were
treated with different concentrations of RELM extract
(50 mg/kg b. wt, 100 mg/kg b. wt, and 250 mg/kg b. wt) and
cyclophosphamide (10 mg /kg b. wt) for 10 days. The
development of ascites tumors in all the animals were noted
and the increase in life span (ILS) of animals was calculated:
% ILSZ ðTCÞ=C 100
where T and C are the average number of days the treated
and control animals survived.
2.6. Statistical analysis
Values are expressed as mean  standard error of the mean
(SEM); analyzed using one-way analysis of variance (ANOVA)
and significance was determined by Duncan’s, Tukey
Kramer multiple comparisons, or Dunnet multiple range
test using SPSS version 17 (SPSS Inc., Chicago, IL, USA) and
Graphpad (GraphPad Software, Inc., 7825 Fay Avenue,
Suite 230, La Jolla, CA 92037, USA).e peroxidase
protein)
Catalase
(U/mg protein)
Superoxide dismutase
(U/mg protein)
 1.50 3.64  1.66 0.87  1.23
 1.82 3.55  1.03 0.91  2.62
 1.55* 4.01  0.70 1.01  0.42
 1.09y 5.23  0.55* 1.29  0.93
Z 6).
ontrol. b. wt Z body weight; CMC Z carboxy methyl cellulose;
T
a
b
le
3
E
ff
e
ct
o
f
R
E
LM
o
n
e
xc
is
io
n
a
n
d
St
a
p
h
yl
o
co
cc
u
s
a
u
re
u
s-
in
fe
ct
e
d
w
o
u
n
d
s.
G
ro
u
p
s
M
e
a
n
p
e
rc
e
n
ta
ge
o
f
w
o
u
n
d
co
n
tr
a
ct
io
n

SE
M
P
e
ri
o
d
o
f
e
p
it
h
e
li
a
li
za
ti
o
n
(d
a
ys
)
SO
D
a
ct
iv
it
y
o
f
gr
a
n
u
lo
m
a
ti
ss
u
e
(U
/m
g
p
ro
te
in
)
D
a
y
3
D
a
y
12
D
a
y
21
E
xc
is
io
n
In
fe
ct
e
d
E
xc
is
io
n
In
fe
ct
e
d
E
xc
is
io
n
In
fe
ct
e
d
E
xc
is
io
n
In
fe
ct
e
d
E
xc
is
io
n
In
fe
ct
e
d
C
o
n
tr
o
l
12
.6
1

2.
31
15
.3
8

3.
7
44
.0
0

2.
58
23
.6
2

1.
6
73
.8
0

2.
5
67
.2
9

1.
4
27
.0
0

0.
03
35
.8
2

0.
95
0.
87

0.
24
0.
85

0.
76
B
e
ta
d
in
e
(5
%
w
/w
)
23
.9
6

2.
3*
19
.0
1

2.
38
10
0.
0

1.
0*
81
.2
0

1.
32
*
10
0.
0

0.
0*
10
0.
00

0.
0*
12
.6
2

0.
06
*
15
.0
1

0.
02
*
1.
28

0.
24
1.
29

0.
54
N
e
o
m
yc
in
(5
%
w
/w
)
d
20
.4
7

2.
77
d
10
0.
00

0.
02
*
d
10
0.
00

0.
0*
d
12
.0
6

0.
11
*
d
1.
31

0.
35
O
in
tm
e
n
t
b
a
se
14
.4
6

1.
94
19
.8
7

2.
9
56
.3
2

1.
25
*
38
.4
6

2.
1*
82
.5

1.
70
*
75
.4
5

2.
4*
23
.3
9

0.
82
*
29
.1
4

0.
84
*
0.
85

0.
15
0.
89

0.
54
R
E
LM
1
14
.3
0

2.
54
22
.4
4

1.
8y
69
.0
3

1.
52
*
60
.2
3

1.
9*
10
0.
0

0.
0*
10
0.
00

0.
0*
18
.0
1

0.
02
*
19
.5
8

0.
21
*
1.
14

0.
61
1.
08

0.
45
R
E
LM
2
8.
68

1.
8
13
.2
7

2.
53
94
.2
3

1.
9*
79
.2
5

1.
09
*
10
0.
0

0.
0*
10
0.
00

0.
0*
13
.8
4

0.
09
*
15
.0

0.
00
*
1.
26

0.
49
1.
15

0.
62
V
a
lu
e
s
a
re
e
xp
re
ss
e
d
a
s
m
e
a
n

st
a
n
d
a
rd
e
rr
o
r
o
f
th
e
m
e
a
n
(S
E
M
),
n
Z
8
a
n
im
a
ls
in
e
a
ch
gr
o
u
p
.
T
h
e
tr
e
at
e
d
gr
o
u
p
s
a
re
co
m
p
ar
e
d
w
it
h
th
e
co
n
tr
o
l
gr
o
u
p
.
*p
<
0.
00
1,
y p
<
0.
05
.
R
E
LM
1,
R
E
LM
2
Z
R
u
b
u
s
e
ll
ip
ti
cu
s
ro
o
t
a
ce
to
n
e
e
xt
ra
ct
o
f
1%
a
n
d
2%
w
/w
o
in
tm
e
n
t;
SO
D
Z
su
p
e
ro
xi
d
e
d
is
m
u
ta
se
.
R. ellipticus Wound Healing & Antitumor Properties 1373. Results
3.1. In vitro antioxidant activities of R. ellipticus
The RELM extract was found to scavenge the stable free
radical DPPH significantly (p < 0.001) with an inhibitory
concentration 50 (IC50) value of 6.96 mg/mL, which was
compared with the standards butylated hydroxytoluene
(BHT; 13.18 mg/mL; p < 0.01), butylated hydroxyanisole
(BHA; 4.88umg/mL; p < 0.001), rutin (5.80 mg/mL;
p < 0.001), and quercetin (4.12 mg/mL; p < 0.001),
respectively (Table 1). One hundred mg/mL of RELM extract
was found to inhibit 71.08% nitric oxide free radicals when
compared to BHT and rutin (p < 0.001). RELM significantly
inhibited 66.08% of superoxide radicals, which was com-
parable to the standards BHA and BHT (p < 0.001).
3.2. In vivo antioxidant activities of RELM
Because the RELM extract showed a strong in vitro antiox-
idant activity, it was taken for evaluation of in vivo anti-
oxidant activity. The activity of GSH, GPx, CAT, and
SOD were effectively increased in groups treated with
100 mg/kg b. wt and 250 mg/kg b. wt RELM extract
compared to untreated control groups. The GSH level
significantly increased in both 100 mg/kg b. wt (p < 0.05)
and 250 mg/kg b. wt (p < 0.01) treated groups. GPx, CAT,
and SOD levels were found to be increased significantly
(p < 0.05) in 250 mg/kg b. wt (Table 2).
3.3. Wound healing properties of RELM
The toxicity study shows safety of the extract up to a
maximum dose of 2 g/kg. Hence, two doses were selected
for this study, i.e., 100 mg/kg and 200 mg/kg. The mean
percentage of contraction of the wound area in the excision
and infected models was calculated on postwounding Day
3, Day 6, Day 9, Day 12, Day 15, Day 18, and Day 21. In the
excision model, the percentage closure of the wound area
had significantly increased (from p < 0.05 to p < 0.001) by
the curative effect of both doses (1% and 2%) by decreasing
the epithelialization period (18.01 days and 13.84 days,
respectively) as evidenced by the shorter period for fall of
escher compared to standard (12.62) and control (27.00).
The 2% acetone extract-treated groups demonstrated
94.23% contraction on the 12th day, which was close to the
contraction value with Betadine (100% on the 12th day;
Table 3).
A very rapid contraction of the infected wound was
observed in standard, 1%, and 2% RELM-treated groups from
the 12th day to the 19th day postsurgery when compared to
other groups. On Day 12, the 2% RELM-treated group
showed significant (p < 0.001) similarity to the 5%
Betadine-treated group. On Day 12, the mean percentage
of wound contraction of control, vehicle, Betadine,
Neomycin, 1%, and 2% RELM-treated groups were 23.62%,
38.46%, 81.20%, 100%, 60.23%, and 79.25%, respectively. A
complete epithelialization was noticed on the 12th day for
the 2% extract-treated group. The period of complete
epithelialization was delayed by 4 days in the 1% treated
groups, and for control and vehicle it was delayed by 20
Figure 1 Histopathological view of excision and infected excision wound healing. Epidermal/dermal remodeling in the Day 12
tissue taken from excision model (1, RELM 1%; 2, RELM 2%; 3, control; and 4, Betadine) and infected excision model (5, RELM 1%; 6,
RELM 2%, 7, control; 8, Betadine; and 9, Neomycin) animals. Skin sections show the H&E-stained epidermis and dermis. The
granuloma tissue section of control rats showing incomplete healing with less epithelialization and lesser collagen formation
indicated the incomplete wound healing. Complete healing occurred in the standard and extract-treated rats with elevated
epithelialization and increased collagen formation. H&EZ hematoxylin and eosin; RELMZ Rubus ellipticus leaf methanol extract.
138 B.P. George et al.days and 14 days, respectively, when compared to the 2%
treated group. The SOD activity was found to be slightly
increased in all the groups of animals; this indicates a
possible mechanism to reduce oxidative stress. Compared
to the control groups, SOD levels were significantly
increased in 1% and 2% RELM-treated groups.
Hematoxylin and eosin (H&E)-stained slides were eval-
uated for demonstration of the healing process (Fig. 1).
Phases in wound healing processes were observed success-
fully within the experimental groups. The histopathologicalTable 4 Effect of RELM1 and RELM2 on healing of incision
wounds.
Groups Tensile strength
mean  SEM (N/cm2)
Control 33.50  1.2
StandardeBetadine 67.31  1.03*
Normal skin 70.28  0.9*
RELM1 39.57  1.09y
RELM2 42.45  1.34*
Values are expressed as mean  standard error of the mean
(SEM), n Z 6 animals in each group.
The treated groups are compared with the control group:
*p < 0.001,
y
p < 0.01. RELM1, RELM2 Z Rubus ellipticus root
acetone extract of 1% and 2% w/w ointment.evaluation revealed that the original tissue regeneration
was much greater in standard and RELM-treated groups.
The tensile strength in the animals of the treatment groups
(1% and 2%)were significantly (p< 0.01 and p< 0.001) greater
than that of the control in the incision model. The tensile
strength of the animals was 42.45 N/cm2 (2%), 39.57 N/cm2
(1%), 67.31 N/cm2 (Betadine), 70.28 N/cm2 (normal skin), and
33.50 N/cm2 (control), respectively (Table 4).
3.4. Antitumor activities of RELM
The effect of RELM in the reduction of a solid tumor
induced by DLA cells is shown in Fig. 2. The tumor volume of
mice treated with RELM was found to be significantly lower
than untreated and vehicle (0.1% CMC) controls. The tumor
volumes of the untreated and vehicle control animals on
the 38th day (10th reading) were 4.06 cm3 and 3.85 cm3,
respectively, whereas the tumor volumes of the animals
treated with 250 mg/kg b. wt, 100 mg/kg b. wt, and 50 mg/
kg b. wt RELM extract were 2.56 cm3, 2.13 cm3, and
3.07 cm3, respectively, on the 38th day. RELM also showed a
significant reduction of solid tumor volume in Swiss albino
mice when injected subcutaneously.
The effect of the RELM extract on ascites tumor devel-
opment is shown in Table 5. All the control animals died of
EAC tumor by 19.16 days. All the treated groups showed an
increase in life span of animals bearing EAC tumors. The
administration of RELM significantly (p < 0.001, p < 0.01)
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Figure 2 The effect of Rubus ellipticus leaf methanol extract on solid tumor development is shown in the graph. A dose-
dependent decrease in the tumor volume was observed; the untreated and vehicle-treated groups showed 4.06 cm3 and
3.85 cm3 tumor volume on the 38th day, which was significantly higher than that of the standard and extract-treated groups.
R. ellipticus Wound Healing & Antitumor Properties 139reduced ascites tumor development by EAC cells when
injected intraperitoneally. However, cyclophosphamide
(10 mg/kg) was found to be more effective and increased
the life span of animals by 83.56% (p < 0.001) whereas RELM
250 mg/kg, 100 mg/kg, and 50 mg/kg showed 45.76%,
39.93%, and 22.76% increase in life span, respectively.
4. Discussion
Dall’ Acqua [23] carried out DPPH method with the leaf
methanol extract of Rubus ulmifolius to evaluate the
antioxidant potential and confirmed that the activity is
related to the nature of phenolics; thus contributing to
their electron transfer/hydrogen donating ability. A similar
effect has been shown by R. ellipticus extracts also. The
protective effects of R. ellipticus fruit on the glucose
tolerance test and alloxan-induced diabetes were evalu-
ated [24]. The R. ellipticus fruit extracts exhibited a sig-
nificant antidiabetic effect in experimental models of
diabetes mellitus.Table 5 Effect on Rubus ellipticus leaf methanol extract
on ascites tumor development.
Groups Mean survival
(days)
Increase in
lifespan (%)
Control (tumor alone) 19.16  0.85 d
Vehicle control (0.1% CMC) 20.18  0.92 d
Cyclophosphamide
(10 mg/kg)
35.17  1.12y 83.56
R. ellipticus leaf methanol
extract (250 mg/kg)
28.12  1.58y 46.76
R. ellipticus leaf methanol
extract (100 mg/kg)
26.81  2.01y 39.93
R. ellipticus leaf methanol
extract (50 mg/kg)
23.52  1.92* 22.76
Values are expressed as mean  standard error of the mean
(SEM) (n Z 6).
Significantly different at *p < 0.01,
y
p < 0.001 when compared
to control. CMC Z carboxy methyl cellulose.The plant products may have the property to counteract
the effect of NO formation and in turn may be of consid-
erable interest in preventing the ill effects of excessive NO
generation in the human body. Further, the scavenging
activity may also help to arrest the chain of reaction initi-
ated by the excess generation of NO that is detrimental to
human health [25]. Because R. ellipticus showed good NO
scavenging activity, it is clear that it can be used for
scavenging reactive nitrogen species in human body. The
human body has several mechanisms to counteract the
damage by free radicals; these act on different oxidants as
well as in different cellular compartments. One important
line of defense is a system of antioxidant enzymes such as
SOD, catalase, and GPX. SOD is a metalloprotein, which
converts superoxide radicals into H2O2. To eliminate H2O2,
organisms use catalaseda homotetrameric ferri heme
containing enzyme and/or GPX, a selenium-dependent
enzyme. The Km value for GPX is lower than that for cata-
lase and hence GPX is considered most important in phys-
iological conditions. GSH is abundant in most cellsdit is an
important substrate for GPX by quenching free radicals
[26]. The results of this study clearly shows that the RELM
extract could effectively raise the levels of in vivo antiox-
idants in treated animals, and it may act as a defense
system in the human body to counteract oxidative stress.
The aerial parts of Rubus sanctus promote wound healing
activity in animals as shown in a preclinical study using both
incision and excision models [27]. Flavonoids and their de-
rivatives are known to decrease lipid peroxidation by
improving vascularity and by preventing or slowing down the
progress of cell necrosis. Hence, any drug that inhibits lipid
peroxidation is supposed to increase the viability of collagen
fibrils by increasing the circulation and strength of collagen
fibers, by encouraging DNA synthesis, and preventing cell
damage [28]; these factors enhance wound healing. There-
fore, the wound healing potential of R. ellipticus may be
attributed to the phytoconstituents in leaves, which may be
either due to their individual or additive effect.
There are reports that extracts from plants such as
Emblica officinalis [29], Phyllanthus amarus [22], Curcuma
longa [30], Picrorhiza kurroa [31] and Piper longum [32]
140 B.P. George et al.have antitumor, immunomodulatory, and anticarcinogenic
activities; all these plants have shown strong antioxidant
potential also. These observations suggest that the effect
of the RELM extract to inhibit the incidence and progression
of tumors is essentially due to its antioxidant activities. The
R. ellipticus extract was found to have significant activity
against DLA- and EAC-induced solid and ascites tumors.
The anti-inflammatory, analgesic, and antipyretic ac-
tivities of R. ellipticus and a closely related species of
Rubus, Rubus niveus, have been reported by George
et al [5,33]. Johnston et al [34] studied the acupuncture-
enhanced anticancer immune functions of natural killer
(NK) cells. The research provides background information
on acupuncture, summarizes the current scientific under-
standing of the mechanisms through which NK cells act to
eliminate cancer cells, and reviews evidence that
acupuncture is associated with increases in NK cell quantity
and function in both animals and humans. Compelling
research findings demonstrate that acupuncture reduces
the incidence of chemotherapy-induced acute vomiting
[35] and potentially manages the cancer-related pain of
articular and soft tissue origin [36,37]. Promising evidence
suggests that acupuncture relieves fatigue in cancer pa-
tients and survivors [38,39]. Therefore, a combinatorial
therapy including acupuncture and herbal treatment mo-
dalities could impart a synergistic effect on cancer treat-
ment. In this study, the R. ellipticus leaf methanol extract
processed significant wound healing and appreciable asci-
tes and solid antitumor activities, more than likely due to
its strong in vitro and in vivo antioxidant properties. It may
also stimulate the NK cells to elevate the anticancer im-
mune functions of acupuncture-enhanced cancer therapy.
The present study demonstrated that RELM was effec-
tive in wound healing and reduction of tumor progression.
This may lead to the utilization of R. ellipticus as a phy-
totherapeutic agent for the treatment of free radical-
related or -generated disorders.
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